Logo image of ASTH

ASTRANA HEALTH INC (ASTH) Stock Earnings & Estimates

USA - NASDAQ:ASTH - US03763A2078 - Common Stock

27.77 USD
-2.02 (-6.78%)
Last: 9/19/2025, 8:00:00 PM
27.77 USD
0 (0%)
After Hours: 9/19/2025, 8:00:00 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031
Revenue
YoY % growth
ASTH revenue by date.ASTH revenue by date.
1.144B
47.84%
1.387B
21.19%
2.035B
46.72%
3.274B
60.92%
4.175B
27.52%
4.567B
9.39%
4.778B
4.62%
5.149B
7.76%
5.547B
7.73%
5.971B
7.64%
EBITDA
YoY % growth
ASTH ebitda by date.ASTH ebitda by date.
121.808M
5.28%
102.361M
-15.97%
117.277M
14.57%
204.14M
74.07%
270.77M
32.64%
341.77M
26.22%
387.6M
13.41%
437.58M
12.89%
493.68M
12.82%
555.9M
12.60%
EBIT
YoY % growth
ASTH ebit by date.ASTH ebit by date.
104.265M
6.20%
84.613M
-18.85%
89.35M
5.60%
125.05M
39.96%
205.78M
64.56%
216.03M
4.98%
268.26M
24.18%
313.14M
16.73%
363.12M
15.96%
417.18M
14.89%
Operating Margin
ASTH operating margin by date.ASTH operating margin by date.
9.11%6.10%4.39%3.82%4.93%4.73%5.61%6.08%6.55%6.99%
EPS
YoY % growth
ASTH eps by date.ASTH eps by date.
1.06
-32.48%
1.32
24.53%
0.89
-32.58%
1.31
47.59%
2.08
58.46%
2.65
27.45%
3.05
14.97%
3.55
16.39%
4.03
13.51%
4.55
12.91%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth
0.45
36.39%
0.44
393.25%
0.45
219.11%
0.46
141.58%
0.66
47.50%
0.67
52.42%
0.56
24.89%
0.64
39.33%
0.64
-3.97%
0.64
-4.01%
Revenue
Q2Q % growth
971.84M
103.01%
1.003B
50.78%
1.003B
61.67%
936M
42.94%
1.069B
10.00%
1.104B
10.07%
1.024B
2.09%
1.055B
12.71%
1.035B
-3.18%
1.047B
-5.16%
EBITDA
Q2Q % growth
69.08M
43.24%
68.69M
139.78%
61.835M
125.41%
64.823M
90.14%
73.793M
6.82%
75.398M
9.77%
68.645M
11.01%
73.769M
13.80%
73.463M
-0.45%
73.205M
-2.91%
EBIT
Q2Q % growth
48.117M
69.28%
45.607M
6,234.31%
41.036M
99.37%
43.382M
113.28%
56.613M
17.66%
59.063M
29.50%
24.259M
-40.88%
30.932M
-28.70%
31.773M
-43.88%
33.16M
-43.86%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2025
Q2Q % growth
0.19
-52.50%
0.37-0.18-48.70%
Q1 2025
Q2Q % growth
0.14
-54.84%
0.25-0.11-44.39%
Q4 2024
Q2Q % growth
-0.15
-157.69%
0.12-0.27-225.16%
Q3 2024
Q2Q % growth
0.33
-29.79%
0.320.011.74%
Q2 2024
Q2Q % growth
0.40
42.86%
0.400.000.55%
Q1 2024
Q2Q % growth
0.31 0.310.000.75%
Q4 2023
Q2Q % growth
0.26
533.33%
0.150.1171.85%
Q3 2023
Q2Q % growth
0.47
-16.07%
0.340.1339.63%
Q2 2023
Q2Q % growth
0.28
12.00%
0.260.039.80%
Q1 2023
Q2Q % growth
0.31 0.310.00-0.90%
Q4 2022
Q2Q % growth
-0.06
-120.00%
-0.090.0334.64%
Q3 2022
Q2Q % growth
0.56
-18.84%
0.320.2472.38%
Q2 2022
Q2Q % growth
0.25
-10.71%
0.210.0420.74%
Q1 2022
Q2Q % growth
0.31
3.33%
0.33-0.02-5.02%
Q4 2021
Q2Q % growth
0.30
11.11%
0.270.0310.99%
Q3 2021
Q2Q % growth
0.69
53.33%
0.350.3498.96%
Q2 2021
Q2Q % growth
0.28
116.00%
0.210.0730.72%
Q1 2021
Q2Q % growth
0.30
172.73%
0.220.0833.69%
Q4 2020
Q2Q % growth
0.27
50.00%
0.180.0947.06%
Q3 2020
Q2Q % growth
0.45
350.00%
0.220.23100.53%
Q2 2020
Q2Q % growth
-1.75
-2,044.44%
0.07-1.82-2,550.98%
Q1 2020
Q2Q % growth
0.11 0.040.07169.61%
Q4 2019
Q2Q % growth
0.18 0.20-0.02-11.76%
Q3 2019
Q2Q % growth
0.10 0.14-0.04-29.97%
Q2 2019
Q2Q % growth
0.09 0.050.0476.47%
Q1 2019
Q2Q % growth
0.00 0.08-0.08-100.00%
ASTH Yearly EPS VS EstimatesASTH Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 1 2 3 4
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2025
Q2Q % growth
654.808M
34.66%
651.09M3.718M0.57%
Q1 2025
Q2Q % growth
620.39M
53.43%
643.29M-22.9M-3.56%
Q4 2024
Q2Q % growth
665.209M
88.43%
629.59M35.619M5.66%
Q3 2024
Q2Q % growth
478.71M
37.49%
471.62M7.09M1.50%
Q2 2024
Q2Q % growth
486.265M
39.65%
449.57M36.695M8.16%
Q1 2024
Q2Q % growth
404.356M
19.90%
422.13M-17.774M-4.21%
Q4 2023
Q2Q % growth
353.036M
40.79%
347.99M5.046M1.45%
Q3 2023
Q2Q % growth
348.173M
26.61%
357.1M-8.927M-2.50%
Q2 2023
Q2Q % growth
348.209M 348.81M-601K-0.17%
Q1 2023
Q2Q % growth
337.244M 324.43M12.814M3.95%
Q4 2022
Q2Q % growth

41.09%
250.76M%
Q3 2022
Q2Q % growth

51.46%
274.99M%
Q4 2021
Q2Q % growth

5.92%
177.73M%
Q3 2021
Q2Q % growth

6.39%
181.56M%
Q2 2021
Q2Q % growth

4.65%
174.32M%
Q1 2021
Q2Q % growth

3.33%
175.17M%
Q4 2020
Q2Q % growth

7.03%
167.79M%
Q3 2020
Q2Q % growth

1.20%
170.65M%
Q2 2020
Q2Q % growth

22.83%
166.57M%
Q1 2020
Q2Q % growth

26.39%
169.52M%
ASTH Yearly Revenue VS EstimatesASTH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 1B 2B 3B 4B 5B
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS-4.03% 12.16% 7.82% 5.16%
Revenue0.15% 33.01% 10.09% 19.31%